| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = -$305,703 ) |
| | 2026 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21DA063306 | GPR6: A Circuit-Level Druggable Target in Cocaine Use Disorder | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI146227 | Mechanistic function of HCV NS5A targeted by the potent inhibitors | 000 | 5 | NIH | 11/24/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21ES034956 | Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrin | 000 | 1 | NIH | 11/20/2025 | $0 |
| | 2026 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R00DC016328 | Determining the roles of Ca2+-binding proteins in modulation of hair cell mechanotransduction | 000 | 5 | NIH | 11/25/2025 | -$351 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | UG3DA052282 | NOP Receptor Antagonist for OUD Pharmacotherapy | 000 | 1 | NIH | 10/1/2025 | -$206,131 |
| | 2026 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK106229 | Hypothalamic-Striatal Control of Motivation for Obesogenic Food | 000 | 4 | NIH | 10/1/2025 | $0 |
| | 2026 | 2019 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI125434 | Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections | 000 | 3 | NIH | 10/1/2025 | -$99,221 |
|
| Issue Date FY: 2025 ( Subtotal = $93,791,920 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01NS137812 | Tunneling nanotubes are a novel mechanism for the propagation of HIV infection and neurodegeneration | 000 | 2 | NIH | 8/8/2025 | $197,345 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34AR084669 | Integrated spatial omics to elucidate conserved inflammatory mechanisms of vesicant-induced skin injury | 001 | 2 | NIH | 8/12/2025 | $1 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34AR084669 | Integrated spatial omics to elucidate conserved inflammatory mechanisms of vesicant-induced skin injury | 001 | 2 | NIH | 8/12/2025 | $182,239 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG088215 | The function of post-translational modifications of myosin and its chaperone UNC-45 that occur with adult aging | 001 | 2 | NIH | 7/14/2025 | $550,655 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI168622 | One-Health Approach to Study Human Fasciola hepatica Transmission and Inform Strategic Control | 000 | 4 | NIH | 4/25/2025 | $467,735 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R61AI179997 | Generation of Orientia tsutsugamushi mutant strains for pathogenesis research | 000 | 2 | NIH | 12/17/2024 | $278,013 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31HL172519 | The regulatory impact of transposable elements (TEs) on differential gene expression in closely related species during cellular differentiation | 000 | 2 | NIH | 8/18/2025 | $38,559 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM151324 | Dissecting the Mechanisms of Quaking-Regulated RNA Processing | 000 | 3 | NIH | 6/5/2025 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS131507 | The role of neuro-immune interactions in PACAP induced migraine | 000 | 2 | NIH | 1/15/2025 | $449,651 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 001 | 2 | NIH | 9/19/2025 | $103,494 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH134761 | Targeting cell-to-cell communication to prevent bystander damage mediated by viral reservoirs | 000 | 2 | NIH | 1/10/2025 | $586,466 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01HL171461 | FGF21 protects from progressive metabolic syndrome after undernutrition refeeding | 000 | 2 | NIH | 8/30/2025 | $132,116 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | RM1NS128787 | Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain | 001 | 4 | NIH | 8/4/2025 | $1,733,153 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 4 | NIH | 11/7/2024 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34MH136826 | Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas | 002 | 2 | NIH | 7/9/2025 | $11,479 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R34MH136826 | Leveraging video logs as a bridge to pre-exposure prophylaxis (PrEP) with tailored messaging to Black women and their healthcare providers in Texas | 002 | 2 | NIH | 7/9/2025 | $325,747 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034616 | Anti-Aging Molecule Sirt6 in Neuroprotection in Diabetic Retina | 000 | 3 | NIH | 4/11/2025 | $541,883 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 000 | 2 | NIH | 7/17/2025 | $500,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U2CTR004868 | A Translational Center for Microphysiological Systems-Based Drug Development Tools for Pregnancy and Women's Health | 000 | 2 | NIH | 7/17/2025 | $996,973 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 001 | 3 | NIH | 8/12/2025 | $32,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM149683 | Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability | 000 | 3 | NIH | 1/21/2025 | $288,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01NS130839 | Regulation of HTT-mediated DNA damage repair and chromatin remodeling Complexes | 000 | 3 | NIH | 8/13/2025 | $666,180 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184781 | Pre-clinical studies to repurpose FDA-approved adenosine A2A receptor antagonists for lethal rickettsial infection | 000 | 1 | NIH | 6/11/2025 | $463,698 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM150459 | Dynamic regulatory impact of human transposable elements on gene expression | 000 | 3 | NIH | 5/19/2025 | $387,465 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 000 | 3 | NIH | 12/9/2024 | $424,750 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI176297 | Nanoparticle-encapsulated Epigenetic Inhibitors for Treatment of Inflammatory Bowel Diseases | 000 | 2 | NIH | 12/16/2024 | $192,543 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F30AG085974 | Mechanisms of trans-synaptic pathological tau spreading in the human brain | 000 | 2 | NIH | 7/28/2025 | $48,786 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA060221 | Frustration effects on drug taking | 000 | 2 | NIH | 4/23/2025 | $400,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG089708 | Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease | 001 | 2 | NIH | 4/28/2025 | $20,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG089708 | Selective vulnerability and resilience to trans-synaptic pathological tau spreading in Alzheimers disease | 000 | 2 | NIH | 3/27/2025 | $180,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 001 | 9 | NIH | 6/18/2025 | $61,379 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG054025 | Formation and Propagation of Tau Oligomeric Strains in Alzheimer's Disease | 000 | 9 | NIH | 3/14/2025 | $690,520 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HL181469 | C type Lectin Pathway Regulates Macrophage Immune Metabolism in Mtb-Infected Lung | 000 | 1 | NIH | 8/21/2025 | $788,478 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG077484 | Immunotherapy Targeting Tau Aggregate Polymorphs | 000 | 2 | NIH | 7/15/2025 | $614,629 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 4 | NIH | 3/9/2025 | $198,400 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 4 | NIH | 3/9/2025 | $50,000 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI184534 | Human papillomavirus and risk to pregnancy: a cohort study | 000 | 1 | NIH | 9/2/2025 | $811,033 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI189734 | Assessing desiccation tolerance's impact on Aedes aegypti midgut infection | 000 | 1 | NIH | 9/8/2025 | $2,536,503 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY037745 | The Role of Sirt6 in Acrolein-Induced Ocular Injury | 000 | 1 | NIH | 9/10/2025 | $1,434,104 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R33AG078519 | Developing, Implementing, and Evaluating a Caregiver and Elder Abuse Screening, Risk Assessment and Treatment to Improve Outcomes for Older and Vulnerable Adults with MCI/ADRD | 000 | 3 | NIH | 9/17/2025 | $738,817 |
| | 2025 | 2025 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI193714 | Creation of a transgenic pig model permissive to HBV infection | 000 | 1 | NIH | 8/6/2025 | $440,000 |
|
